Gene · 6792
Papers1,482
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,482
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Neurodegeneration Biomarkers in Epilepsy: A Critical Review of Current Findings. | Life (Basel) | 2026 | 41752932 | PubTator, text mining | PubMed |
| Molecular Profiling of Polish Pediatric Patients with Epilepsy: A Single-Center Diagnostic Experience Using Next-Generation Sequencing. | Genes (Basel) | 2026 | 41751517 | PubTator, text mining | PubMed |
| Generative Artificial Intelligence-Enabled Saliency Analysis of Eye Tracking in Cerebral/Cortical Visual Impairment (SET-CVI). | Ophthalmol Sci | 2026 | 41743165 | PubTator, text mining | PubMed |
| Distinct molecular pathways leading to dosage-dependent temozolomide resistance in GBM stem cells. | Cancer Cell Int | 2026 | 41736030 | PubTator, text mining | PubMed |
| Role of autophagy in antiviral innate immunity. | Cell Mol Biol Lett | 2026 | 41735833 | PubTator, text mining | PubMed |
| Case Report: A female case of X-linked intellectual disability syndrome type 34 caused by a NONO frameshift variant and literature review. | Front Pediatr | 2026 | 41727761 | PubTator, text mining | PubMed |
| Cell-specific roles for the conserved Galpha chaperone RIC-8 in cilia biology. | bioRxiv | 2026 | 41727026 | PubTator, text mining | PubMed |
| Genetic-Epigenetic Interplay in Epilepsy: Pathways, Biomarkers, and Epigenome-Targeted Therapies. | Epigenomes | 2026 | 41718408 | PubTator, text mining | PubMed |
| CDKL5 modulates the plasticity of excitatory synapses via liquid-liquid phase separation. | Proc Natl Acad Sci U S A | 2026 | 41706882 | PubTator, text mining | PubMed |
| Atrophin 1-Related CHEDDA Syndrome Associated with Different Inheritance and Epileptic Encephalopathy with Hand Stereotypies. | Ann Indian Acad Neurol | 2026 | 41692690 | PubTator, text mining | PubMed |
| Developmental and Epileptic Encephalopathy due to Cyclin-Dependent Kinase-Like 5 Deficiency: A Single-Center Experience Across Sex Differences. | Pediatr Neurol | 2026 | 41619470 | PubTator, text mining | PubMed |
| Unexpectedly competent immune response to SARS-CoV-2 vaccination in Rett syndrome. | Hum Vaccin Immunother | 2026 | 41605700 | PubTator, text mining | PubMed |
| Clinical Validation of α-Synuclein in Salivary Extracellular Vesicles as a Biomarker for Parkinson's Disease: A Longitudinal Study. | Eur J Neurol | 2026 | 41603154 | PubTator, text mining | PubMed |
| Baseline characteristics and feasibility of clinical outcome measures in CDKL5 deficiency disorder: The CANDID observational study. | Epilepsia | 2026 | 41531035 | PubTator, text mining | PubMed |
| An Overview of Drug-Resistant Epilepsies Based on Advances in Genetics: A Cohort Study. | Neurol India | 2026 | 41510857 | PubTator, text mining | PubMed |
| Exploring sleep challenges in CDKL5 Deficiency Disorder. | J Neurodev Disord | 2026 | 41484992 | PubTator, text mining | PubMed |
| CDKL5 regulates the initiation of retrograde axonal transport through CLIP170-dynactin complex formation. | FEBS J | 2026 | 40847610 | PubTator, text mining | PubMed |
| Cortical Visual Impairment Across a Range of Neurodevelopmental Disorders: Clinical Characterization, Diagnostic Tool Evaluation, and Association with Developmental Outcomes. | J Child Neurol | 2026 | 40767165 | PubTator, text mining | PubMed |
| A cross-correction gene therapy approach for CDKL5 deficiency disorder improves the pathological phenotype of CDD patient-derived cortical organoids. | Front Bioeng Biotechnol | 2025 | 41647608 | PubTator, text mining | PubMed |
| Shared Disease Mechanisms in Neurodevelopmental Disorders: A Cellular and Molecular Biology Perspective. | Brain Sci | 2025 | 41594775 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6792/papers?page=2